A public biotech company developing cell-encapsulation therapies using its live-cell encapsulation platform to treat cancer, ...

Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosis Feedback from hepatology community supports US market potential from ...

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...

Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...

(1) The total number of outstanding shares of the Company mentioned in the relevant transparency notification amounts to 65,759,928, each share giving right to one (1) vote (being 65,759,928 voting ...

"One man died of a massive heart attack — so massive that his heart literally burst. You could stick your fingers into the ...

Diabetes and cancer are two of the four major non-communicable diseases identified by WHO. Their relationship is multifaceted ...

Early trial results for a multi-cancer blood test have sparked excitement, but the technology still fails to detect three in ...

A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients ...

Cancer related cognitive impairment in patients can stem from the cancer itself as well as the therapies used to treat it.

Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...